Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06544720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 9, 2024 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
A multicenter, open, single arm dose escalation and dose expansion phase I study to evaluate the safety, tolerability, and efficacy of SCG142 TCR-T cells in Subjects with advanced HPV associated carcinomas.
Trial Details
NCT Number NCT06544720
Lead Sponsor The Affiliated Hospital of Qingdao University
Conditions
(from sponsor)		 Human Papillomavirus Associated Carcinomas, Cervical Cancer, Head and Neck Cancers, Anal Cancer, Vulva Cancer, Vaginal Cancer, Penile Cancer, HPV-Related Malignancy
Related terms Anus Neoplasms, Head and Neck Neoplasms, Penile Neoplasms, Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov